Standard or Short-course Vonoprazan Non-bismuth Triple Therapy or High-dose Dual Therapy Versus Rabeprazole-bismuth Quadruple Therapy for Primary Helicobacter Pylori Eradication

NCT06168214 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

1404

Enrollment

OTHER

Sponsor class

Conditions

the Eradication Rates of Helicobacter Pylori

Interventions

DRUG: Rabeprazloe+bismuth+amoxicillin+clarithromycin
DRUG: Vonoprazan+amoxicillin+clarithromycin 14 days
DRUG: Vonoprazan+amoxicillin+clarithromycin 7 days
DRUG: Vonoprazan+tetracycline+furazolidone 14 days
DRUG: Vonoprazan+tetracycline+furazolidone 7 days
DRUG: Vonoprazan+amoxicillin+furazolidone 7 days
DRUG: Vonoprazan+amoxicillin+tetracycline 14 days
DRUG: Vonoprazan+amoxicillin 7 days
DRUG: Vonoprazan+amoxicillin 14 days

Sponsor

Xijing Hospital of Digestive Diseases